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replication. These defects do not dramatically impair tion forks. Being part of different nucleo-protein com-
plexes, Obg could coordinate different functions bycell viability but they are highly synergistic with a seqA
mutation that independently affects proper timing of sensing an increase in the GDP/GTP pool. Obg-like
proteins are largely conserved from bacteria to eukary-replication initiation. Curiously, control of replication ini-
tiation is also disrupted by overproduction of wild-type otes and are essential for the viability of nearly all or-
ganisms. Understanding the new link that they appearor GTPase-defective ObgE protein. Abnormal replica-
to create between the various cellular processes is ation initiation in the presence of a mutated obg/ctgA
fascinating challenge.allele or upon overproduction of wild-type or mutant
Obg proteins was previously observed in other bacteria
Bénédicte Michel(Datta et al., 2004; Slominska et al., 2002). In yeast,
Génétique Microbiennemaintenance of fork stability after HU treatment de-
Institut National de la Recherche Agronomiquepends on the intra-S checkpoint kinase Rad53, and
78350 Jouy en Josasproteins that may control replication by sensing the nu-
Francecleotide pool have not been identified (Koc et al., 2004).
The intriguing question remains as to how the mul-
tiple roles of Obg are coordinated, namely, its role in
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Who Can Stop These Eggs?
Vertebrate eggs prevent parthenogenetic develop-
ment by producing cytostatic factor (CSF), which
blocks exit from metaphase of meiosis II until fertiliza-
tion. CSF was never purified but recently suspected
to inhibit the anaphase-promoting complex (APC), an
ubiquitin ligase required for entry into anaphase. In a
recent paper in Genes & Development, Schmidt et al.
describe the Xenopus APC inhibitor Erp1, which
seems to be the best candidate yet for the down-
stream effector of CSF activity.
Cytostatic factor (CSF) has been studied extensively in
Xenopus laevis oocytes, which yield cell-free extractsthat faithfully reproduce cell cycle events in vitro. Hor-
monal induction causes immature oocytes, which are
arrested in meiotic prophase, to undergo maturation:
they perform the first meiotic division and then, without
an intervening S phase, proceed to metaphase of the
second division. Fertilization triggers a surge in free
cytoplasmic Ca2+, which causes entry into anaphase
followed by the onset of embryonic (i.e., mitotic) cleav-
age divisions. The classic injection experiments by Ma-
sui and Markert identified two different activities in the
cytoplasm of mature oocytes: maturation-promoting
factor (MPF) induced resumption of meiosis in imma-
ture oocytes, whereas CSF caused metaphase arrest in
cleaving embryos. CSF disappeared shortly after fertil-
ization and, unlike MPF, never reappeared during the
embryonic cell cycles. MPF was eventually purified and
identified as the universal cell cycle regulator cyclin-
dependent kinase 1 (Cdk1) bound to cyclin B. CSF was
never purified, probably because several pathways rather
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302than a single activity contribute to CSF function. Two g
imain strategies have since been used to analyze CSF.
dThe first one was to unravel, step by step, the pathway
Aleading from the resumption of meiosis to the establish-
sment of the metaphase II arrest. A second, more recent,
napproach was to examine regulators of APC activity for
wa role in CSF arrest and release (reviewed in Tunquist
and Maller, 2003).
tAnalysis of the germ cell-specific protein kinase Mos
vprovided the first molecule required to generate CSF
iactivity. Similar to CSF, Mos appears during maturation
2and disappears shortly after fertilization. Mos activates
da MAP kinase cascade whose sole downstream target
cis the kinase p90Rsk. In Xenopus oocytes, this pathway
bprevents complete destruction of Cdk1-cyclin B be-
dtween meiosis I and II by increasing cyclin synthesis
pand counteracting APC-dependent cyclin degradation.
tCdk1-cyclin B activity is required to suppress DNA rep-
Alication after meiosis I and to drive oocytes into meiosis
kII. Once oocytes are in metaphase II, p90Rsk is not re-
Cquired anymore for the maintenance of the CSF arrest.
pHowever, the Mos-dependent pathway contributes
fmore to the CSF arrest than “just” promoting entry into
imeiosis II: in mouse oocytes Mos is required for the
ECSF arrest but not to suppress S phase at the meiosis
dI-to-II transition.
aThe Ca2+ wave at fertilization causes entry into ana-
tphase through activation of the APC, which requires as-
isociation of the complex with the Cdc20 activator.
Ubiquitination by APC-Cdc20 then triggers cyclin de-
qgradation and sister chromatid separation. Because
TAPC-Cdc20 is essential for release from the CSF arrest,
tinhibition of APC-Cdc20 was thought to be CSF’s ulti-
Cmate function. The spindle assembly checkpoint (SAC)
thas been identified as a potent inhibitor of APC-Cdc20.
fIn somatic cells, the SAC is activated by kinetochores
blacking spindle microtubules and blocks anaphase in
iresponse to spindle damage. In Xenopus oocytes, SAC
ncomponents are not activated by kinetochores (be-
Ccause the nucleocytoplasmic ratio is too low) but by
wp90Rsk in the cytoplasm. While SAC components are
orequired to generate CSF activity in Xenopus oocytes,
athey seem to be dispensable for CSF in mouse oocytes.
pThe Mos/MAPK pathway might inhibit APC-Cdc20
sthrough additional mechanisms.
Recently, the APC inhibitor Emi1 has emerged as a C
CSF candidate. Cyclin accumulation in prophase of the C
mitotic cell cycle requires inhibition of APC-Cdc20 by w
Emi1, which is thought to block Cdc20’s ability to in- a
teract with APC substrates. In prometaphase, Emi1 is t
degraded to allow activation of the APC. Phosphoryla- R
tion of a DSGxxS motif in Emi1 creates a “phospho- u
degron,” a docking site for the SCF-βTrCP ubiquitin w
ligase. Exogenous Emi1 causes cell cycle arrest in l
cleaving embryos and blocks cyclin degradation in h
Ca2+-treated CSF extracts, demonstrating that excess r
Emi1 can block both the embryonic and the meiotic
cell cycle. The idea of Emi1 as a CSF component is W
supported by the detection of Emi1 in mature mouse M
oocytes and the finding that phosphorylation by p90Rsk
strengthens Emi1’s interaction with Cdc20 (Paronetto P
et al., 2004). Whether Emi1 is essential for the CSF ar- 0
rest in Xenopus eggs, however, is controversial. One Group reported that Emi1 is more abundant than Cdc20
n CSF extracts and remains stable until the first mitotic
ivision upon Ca2+ release (Reimann and Jackson, 2002).
nother group failed to detect endogenous Emi1 under
imilar conditions and found rapid degradation of exoge-
ous Emi1 in meiotic extracts, which is more consistent
ith Emi1’s behavior in mitosis (Ohsumi et al., 2004).
One solution to these inconsistencies may arise from
he discovery of Thomas Mayer and colleagues that
ertebrates contain an additional conserved APC inhib-
tor, the Emi1-related protein Erp1 (Schmidt et al.,
005). This protein is a prime candidate for the most
ownstream CSF component, at least in Xenopus oo-
ytes: Erp1 appears during maturation, is essential for
locking APC-Cdc20 in metaphase II, and is abruptly
egraded in response to Ca2+. Erp1 was identified as a
rotein binding to polo-like kinase (Plk1) in an effort
o unravel the mechanism by which Plk1 activates
PC-Cdc20 upon fertilization. Inactivation of Plk1 was
nown to prevent cyclin degradation in Ca2+-treated
SF extracts (Descombes and Nigg, 1998). Plk1 can
hosphorylate APC subunits in vitro, but a clear in vivo
unction for these sites failed to emerge, nurturing the
dea that Plk1 might inactivate an APC inhibitor. Indeed,
rp1’s degradation requires phosphorylation of a βTrCP
egron by Plk1 (Schmidt et al., 2005). Interestingly, Plk1
lso phosphorylates the degron of Emi1, suggesting
hat Plk1 has a general role in liberating the APC from
ts inhibitors (Hansen et al., 2004; Moshe et al., 2004).
Plk1 appears early during maturation, when it is re-
uired for the upregulation of Cdk1-cyclin B activity.
his raises the question of how Ca2+ actually triggers
he degradation of Erp1. Plk1 and its kin all contain a
-terminal polo box domain that binds to phosphopep-
ides containing S-pS/pT (Elia et al., 2003). Plk1 there-
ore phosphorylates substrates that have previously
een phosphorylated by a “guiding kinase.” It is tempt-
ng to speculate that Ca2+/camodulin-dependent ki-
ase II (CaMKII) is the kinase that guides Plk1 to Erp1.
aMKII is activated by Ca2+ released upon fertilization,
hile a constitutively active version triggers activation
f APC-Cdc20 even in the absence of Ca2+ (Lorca et
l., 1993). Indeed, Erp1 contains potential CaMKII phos-
horylation sites (RxxS/T) that can generate binding
ites for the polo box domain.
Another question is how Erp1 and Emi1 inhibit APC-
dc20’s ligase activity. Emi1 was reported to bind to
dc20, while no interaction was detected for Erp1;
hether Erp1 can bind to the APC was not tested. Erp1
nd Emi1 inhibit the APC through a C-terminal, cys-
eine-rich region, which resembles an IBR (in between
ING fingers) domain. This domain is thought to bind
biquitin-conjugating enzymes (UBCs) in collaboration
ith the RING finger, which is a hallmark of ubiquitin
igases including the APC. Whether Erp1 and Emi1 in-
ibit the APC by affecting its interaction with the UBC
emains to be tested.
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